735
Participants
Start Date
August 31, 2016
Primary Completion Date
May 26, 2017
Study Completion Date
June 6, 2017
Omadacycline
po tablets
Linezolid
po tablets
Site 647, Jackson Heights
Site 632, Mount Airy
Site 614, DeLand
Site 631, Miami
Site 640, Miami Lakes
Site 656, Homestead
Site 662, Miami Lakes
Site 658, Miami
Site 654, Miami
Site 626, Miami
Site 637, Miami
Site 653, Miami
Site 641, Miami
Site 645, Miami
Site 655, Fort Myers
Site 609, Saint Cloud
Site 620, Birmingham
Site 642, Mobile
Site 628, Smyrna
Site 635, Jackson
Site 649, Toledo
Site 644, Council Bluffs
Site 607, Rapid City
Site 602, Butte
Site 617, St Louis
Site 625, Houston
Site 627, Houston
Site 634, Sugar Land
Site 633, Baytown
Site 605, Channelview
Site 623, Las Vegas
Site 650, Torrance
Site 606, Buena Park
Site 612, Long Beach
Site 604, Chula Vista
Site 608, La Mesa
Site 610, Oceanside
Site 615, San Diego
Site 621, San Diego
Site 659, Huntington Beach
Site 618, Laguna Hills
Site 616, Anaheim
Site 601, Anaheim
Site 646, Ventura
Site 636, Bakersfield
Site 613, San Francisco
Site 603, Stockton
Site 648, Modesto
Site 657, Boston
Site 630, Somers Point
Lead Sponsor
Paratek Pharmaceuticals Inc
INDUSTRY